Portfolio: Overview

DELIVERING VALUE FOR PATIENTS AND INVESTORS

Harnessing our unique investment approach focused on the translational stage of drug development, combined with our agile operating model for company formation and trial execution, Aditum Bio has launched seven companies to date.

 
FUND I SNAPSHOT

Launched in 2019, Fund 1 is fully invested in the formation of six portfolio companies.

FUND II SNAPSHOT

Fund II was launched in 2021 and to-date has invested in the launch of a portfolio company focused on muscle spasticity.

OUR PORTFOLIO COMPANIES